GainersToday.com, Tracking Stock Market Picks
Enter Symbol
:
Home
Upgrades
Downgrades
Gainers
Losers
Rankings
Accuracy
Gains
Trade Avg
Trade
Trade Year
Sectors
Directory
Blog
Tools
Mobile
Gadgets
Login
Sign Up
Ligand Pharmaceuticals Incorporated (LGND)
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas
of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
( Total: 13 Current Stock Recommendations )
Ligand Pharmaceuticals Incorporated
(13)
Hold 23%
Buy 77%
Related companies
China Biologic ...
(4)
Buy 100%
BioSpecifics ...
(5)
Buy 100%
PROLOR Biotech, Inc.
(5)
Buy 100%
Opko Health Inc
(2)
Buy 100%
Flamel Technologies ...
(8)
Buy 100%
Aeterna Zentaris, ...
(12)
Buy 100%
Lannett Co Inc
(4)
Buy 100%
Anika Therapeutics ...
(4)
Buy 100%
Emergent ...
(6)
Buy 100%
Insys Therapeutics ...
(4)
Buy 100%
Released Ratings
Current Recommendations
Ranking
Filter by Gains
:
All
2% Gains or more
5% Gains or more
10% Gains or more
Show
:
Rating:
Buy
LGND
76.82 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $140 by ROTH Capital
Wednesday, Sep 30, 2015 8:25 AM ET
Rating:
Hold LGND
52.22 %
Ligand Pharmaceuticals Incorporated (LGND) upgraded to Hold with price target $93 by Cantor Fitzgerald
Friday, Jun 19, 2015 10:25 AM ET
Rating:
Hold LGND
19.96 %
Ligand Pharmaceuticals Incorporated (LGND) downgraded to Hold with price target $94 by Deutsche Bank
Monday, Jun 15, 2015 12:25 PM ET
Rating:
Buy
LGND
19.96 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $94 by Deutsche Bank
Wednesday, Apr 1, 2015 2:25 PM ET
Rating:
Buy
LGND
42.95 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $102 by CRT Capital
Tuesday, Mar 3, 2015 9:25 AM ET
Rating:
Buy
LGND
70.43 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $74 by Deutsche Bank
Tuesday, Dec 2, 2014 1:25 PM ET
Rating:
Buy
LGND
76.82 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $116 by ROTH Capital
Wednesday, Nov 19, 2014 10:25 AM ET
Rating:
Buy
LGND
692.01 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $91 by Summer Street Research
Monday, Feb 24, 2014 10:25 AM ET
Rating:
Buy
LGND
53.27 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $96 by MLV & Co
Thursday, Feb 13, 2014 8:25 AM ET
Rating:
Buy
LGND
53.27 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $82 by MLV & Co
Monday, Feb 10, 2014 8:25 AM ET
Rating:
Buy
LGND
692.01 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $78 by Summer Street Research
Monday, Jan 27, 2014 9:25 AM ET
Rating:
Buy
LGND
692.01 %
Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $64 by Summer Street Research
Friday, Aug 2, 2013 11:25 AM ET
Rating:
Sell
LGND
52.22 %
Ligand Pharmaceuticals Incorporated (LGND) downgraded to Sell with price target $37 by Cantor Fitzgerald
Friday, Aug 2, 2013 8:25 AM ET
Rating:
Hold LGND
Ligand Pharmaceuticals Incorporated (LGND) rated Hold with price target $26 by Cantor Fitzgerald
Monday, Mar 18, 2013 8:25 AM ET
Rating:
Hold LGND
9.87 %
Ligand Pharmaceuticals Incorporated (LGND) downgraded to Hold with price target $23 by Cantor Fitzgerald
Friday, Jan 4, 2013 8:25 AM ET
Subscribe to our Newsletter.
Your Recent Stocks
Symbol
Last
Change
LGND
86.03
-8.72 %
RSS Feed
|
|
Facebook
|
Twitter
|
Google Plus
Home
|
Terms of Use
|
Advertise
|
FAQ
|
Support Page
|
Contact Us
|
About Us
|
Privacy Policy
Copyright © 2007 GainersToday.com. All rights reserved.